Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KOSDAQ/200670 stock hub

KOSDAQ/200670 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/200670is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
356B
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/200670
In the news

Latest news · KOSDAQ/200670

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.9
P25 9.8P50 17.1P75 31.9
Trailing P/E35.8
P25 12P50 23.1P75 39.5
ROE7.3
P25 -17.1P50 0.7P75 8.5
ROIC11.9
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/200670 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
227
Groups with data
11
Currency
KRW
Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

17
MetricValue
Country
South Korea
Country code
KR
Employees
248
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
KR7200670008
Last refreshed
2026-05-10
Market cap
KRW 356B
Price
KRW 34,500
Price currency
KRW
Rev Per Employee
447,549,814.64x
Sector
Healthcare
Sic
2836
Symbol
kosdaq/200670
Website
https://humedix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
2.55%
FCF yield
1.53%
Forward P/E
8.87x
P/B ratio
2.51x
P/E ratio
35.79x
P/S ratio
3.21x
PE Ratio3 Y
21.26x
PE Ratio5 Y
24.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
14.41%
EBITDA Margin
25.46%
FCF margin
4.9%
Gross margin
39.7%
Gross Profit
KRW 44.1B
Gross Profit Growth
11.86%
Gross Profit Growth Q
-10.23%
Gross Profit Growth3 Y
19.82%
Gross Profit Growth5 Y
14.41%
Net Income
KRW 9.1B
Net Income Growth
-39.91%
Net Income Growth Q
-87.88%
Net Income Growth Years
4%
Net Income Growth3 Y
-0.52%
Net Income Growth5 Y
-2.48%
Pretax Margin
10.22%
Profit Margin
8.17%
Profit Per Employee
KRW 36.6M
Profitable Years
11
ROA
5.11
Roa5y
5.82
ROCE
9.02
ROE
7.26
Roe5y
10.53
ROIC
11.94
Roic5y
12.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

24
MetricValue
Cagr10y
-1.39%
Cagr1y
-12.77%
Cagr3y
8.64%
Cagr5y
1.69%
Div CAGR3
7.05%
Div CAGR5
18.13%
EPS Growth
-39.26
EPS Growth Q
-87.8
EPS Growth Years
4
EPS Growth3 Y
0.03
EPS Growth5 Y
-2.44
FCF Growth
-10.36%
FCF Growth Q
-84.92%
FCF Growth3 Y
-20.48%
OCF Growth
-19.26%
OCF Growth Q
-58.62%
OCF Growth3 Y
-6.94%
OCF Growth5 Y
20.32%
Revenue Growth
12.7x
Revenue Growth Q
-13.11x
Revenue Growth Quarters
2x
Revenue Growth Years
10x
Revenue Growth3 Y
19.63x
Revenue Growth5 Y
18.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
KRW 0.57
Assets
KRW 215.9B
Cash
KRW 54.4B
Current Assets
KRW 118.5B
Current Liabilities
KRW 38.7B
Debt
KRW 32.7B
Debt EBITDA
KRW 1.16
Debt Equity
KRW 0.23
Debt FCF
KRW 6.02
Equity
KRW 142B
Interest Coverage
7.16
Liabilities
KRW 73.9B
Long Term Assets
KRW 97.4B
Long Term Liabilities
KRW 35.2B
Net Cash
KRW 21.6B
Net Cash By Market Cap
KRW 6.07
Net Cash Growth
-4.36%
Net Debt EBITDA
KRW -0.76
Net Debt Equity
KRW -0.15
Net Debt FCF
KRW -3.97
Tangible Book Value
KRW 122.8B
Tangible Book Value Per Share
KRW 13,060
WACC
6.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.06
Inventory Turnover
3.77
Net Working Capital
KRW 26.2B
Quick ratio
2
Working Capital
KRW 79.8B
Working Capital Turnover
KRW 1.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
1.06%
Dividend Growth
46.03%
Dividend Growth Years
2%
Dividend per share
KRW 660
Dividend Years
12
Dividend Yield
1.91%
Ex Div Date
2026-04-02
Last Dividend
KRW 200
Payout Frequency
Semi-Annual
Payout Ratio
41.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-13.07%
1Y total return
-12.76%
200-day SMA
46,882.3
3Y total return
28.22%
50-day SMA
35,615
50-day SMA vs 200-day SMA
50under200
5Y total return
8.74%
All Time High
88,134.9
All Time High Change
-60.86%
All Time High Date
2015-06-26
All Time Low
10,000
All Time Low Change
245%
All Time Low Date
2020-03-19
ATR
1,261.8
Beta
0.48
Beta1y
0.99
Beta2y
0.58
Ch YTD
-14.5
High
34,550
High52
77,200
High52 Date
2025-07-23
High52ch
-55.31%
Low
33,750
Low52
31,600
Low52 Date
2026-04-06
Low52ch
9.18%
Ma50ch
-3.13%
Price vs 200-day SMA
-26.41%
RSI
46.52
RSI Monthly
44.44
RSI Weekly
38.39
Sharpe ratio
0x
Sortino ratio
0.12
Total Return
2.97%
Tr YTD
-14.01
Tr1m
7.31%
Tr1w
-3.23%
Tr3m
-10.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
KRW 16B
Operating Income Growth
-3.9
Operating Income Growth Q
-33.48
Operating Income Growth3 Y
14.36
Operating Income Growth5 Y
4.49
Operating margin
14.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
6,108,579%
Net Borrowing
23,840,822,230
Shares Insiders
1.55%
Shares Institutions
8.66%
Shares Out
10,320,118
Shares Qo Q
0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
KRW 4.6B
Average Volume
41,475.7x
Bv Per Share
13,398.5
CAPEX
KRW -13.7B
Ch10y
-27.19
Ch1m
7.31
Ch1w
-3.23
Ch1y
-14.6
Ch3m
-11.31
Ch3y
21.27
Ch5y
-0.72
Ch6m
-28.65
Change
1.32%
Change From Open
1.62
Close
34,050
Days Gap
-0.29
Depreciation Amortization
12,273,877,010
Dollar Volume
1,276,017,000
Earnings Date
2026-05-12
EBIT
KRW 16B
EBITDA
KRW 28.3B
EPS
KRW 964
F Score
5
FCF
KRW 5.4B
FCF Per Share
KRW 527
Financing CF
20,063,794,070
Fiscal Year End
December
Founded
2,002
Graham Number
17047.29911
Graham Upside
-50.59
Income Tax
KRW 1.3B
Investing CF
-50,354,411,280
Is Primary Listing
1
Last Earnings Date
2026-02-11
Last Report Date
2021-12-31
Last Split Date
2018-12-27
Last Split Type
Forward
Lynch Fair Value
KRW 4,820
Lynch Upside
-86.03
Ma150
42,156.3
Ma150ch
-18.16%
Ma20
34,830
Ma20ch
-0.95%
Net CF
-19,302,598,970
Next Earnings Date
2026-05-12
Open
33,950
P FCF Ratio
65.43
P OCF Ratio
18.56
Payment Date
2026-04-22
Position In Range
93.75
Ppne
57,068,575,380
Price Date
2026-05-08
Price EBITDA
KRW 12.6
Ptbv Ratio
2.9
Relative Volume
0.9x
Revenue
110,992,354,030x
SBC By Revenue
0.74x
Share Based Comp
818,130,880
Tax By Revenue
1.16x
Tax Rate
11.36%
Tr6m
-27.3%
Volume
36,986
Z Score
3.88
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

KOSDAQ/200670 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.9%
$660 annual per share
Payout ratio
+41.5%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+18.1%
2 consecutive years of growth
Total shareholder yield
+3.0%
Next ex-dividend date: 2026-04-02
Performance

KOSDAQ/200670 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-12.8%
S&P 500 1Y: n/a
3Y total return
+28.2%
S&P 500 3Y: n/a
5Y total return
+8.7%
S&P 500 5Y: n/a
10Y total return
-13.1%
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/200670?

Insider, institutional, and short-interest positioning.

Institutional ownership
+8.7%
Share of float held by funds and institutions
Insider ownership
+1.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

KOSDAQ/200670 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.5
Neutral momentum band
Price vs 200-day MA
-26.4%
50/200-day relationship not available
Beta (5Y)
0.48
Less volatile than the market
Sharpe ratio
0.00
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/200670

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/200670 stock rating?

kosdaq/200670 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/200670 analysis?

The full report lives at /stocks/kosdaq/200670/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/200670?

The latest report frames kosdaq/200670 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/200670 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.